A Study to Evaluate the Feasibility of Vaping Cessation Among Adolescents

Overview

About this study

The purpose of this study is to determine the volume of patients presenting to an outpatient adolescent psychiatric clinic that report past 30-day use of a nicotine-containing e-cigarette, and to determine the feasibility of recruiting adolescents into a vaping cessation study involving a text message intervention.

 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • U.S. residence.
  • Adolescents aged 14-17 years old.
  • Past 30-day use of a nicotine-containing e-cigarette.
  • At least some desire to quit vaping (≥ 3 on Likert scale from 1-10)
  • Thinking about quitting some time in the next 6 months.
  • Patients at Mayo Clinic Health System child and adolescent psychiatry or pediatric oupatient clinic.
  • Exclusive ownership of a cell-phone.
  • Currently enrolled in an unlimited text message plan.
  • Intend to keep the cell phone for the next 3 months.

Exclusion Criteria

  • Patients under 14 and over 17 years of age.
  • Active psychosis
  • Inability to read, understand, or speak fluent English

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Eau Claire, Wis.

Mayo Clinic principal investigator

Pravesh Sharma, M.D.

Contact us for the latest status

Contact information:

Pravesh Sharma M.D.

(715) 838-5322

Sharma.Pravesh@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20490730

Mayo Clinic Footer